Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as non-alcoholic steatohepatitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma.
Read More…
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+44-20-74952379
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees10
Next Earnings DateN/A
OptionableNot Optionable
Tiziana Life Sciences (LON:TILS) Frequently Asked Questions
What is Tiziana Life Sciences' stock symbol?
Tiziana Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "TILS."
How were Tiziana Life Sciences' earnings last quarter?
Tiziana Life Sciences PLC (LON:TILS) issued its quarterly earnings results on Thursday, June, 7th. The biotechnology company reported ($6.40) EPS for the quarter, beating analysts' consensus estimates of ($10.00) by $3.60. View Tiziana Life Sciences' Earnings History.
Has Tiziana Life Sciences been receiving favorable news coverage?
News stories about TILS stock have trended negative on Tuesday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Tiziana Life Sciences earned a news impact score of -2.9 on InfoTrie's scale. They also gave headlines about the biotechnology company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Tiziana Life Sciences.
Who are some of Tiziana Life Sciences' key competitors?
Some companies that are related to Tiziana Life Sciences include ProMetic Life Sciences (PLI), Rafael (RFL), CEL-SCI (CVM), Pfenex (PFNX), 22nd Century Group (XXII), Emblem (EMC), Acasti Pharma (ACST), Emerald Health Therapeutics (EMH), Botanix Pharmaceuticals (BOT), Senesco Technologies (ELOX), Monash IVF Group (MVF), Horizon Discovery Group (HZD), Enochian Biosciences (ENOB), Neuren Pharmaceuticals (NEU) and IMV (IMV).
What other stocks do shareholders of Tiziana Life Sciences own?
Who are Tiziana Life Sciences' key executives?
Tiziana Life Sciences' management team includes the folowing people:
- Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA, Founder & Exec. Chairman (Age 47)
- Dr. Kunwar Shailubhai, CEO, Chief Scientific Officer & Exec. Director (Age 61)
- Dr. Andrea Brancale, Scientific Founder
- Mr. Richard Clarkson Ph.D., Scientific Founder
- Mr. Andrew Westwell Ph.D., Scientific Founder
How do I buy shares of Tiziana Life Sciences?
Shares of TILS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Tiziana Life Sciences' stock price today?
One share of TILS stock can currently be purchased for approximately GBX 60.
How big of a company is Tiziana Life Sciences?
What is Tiziana Life Sciences' official website?
How can I contact Tiziana Life Sciences?
Tiziana Life Sciences' mailing address is 3rd Fl, 11-12 St. James's Square, LONDON, SW1Y 4LB, United Kingdom. The biotechnology company can be reached via phone at +44-20-74952379.
MarketBeat Community Rating for Tiziana Life Sciences (LON TILS)
MarketBeat's community ratings are surveys of what our community members think about Tiziana Life Sciences and other stocks. Vote "Outperform" if you believe TILS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TILS will underperform the S&P 500 over the long term. You may vote once every thirty days.
